In vitro activity of efrotomycin, ciprofloxacin, and six other antimicrobials against Clostridium difficile

The susceptibility of 69 clinical isolates of Clostridium difficile from the Minneapolis Veterans Administration Medical Center and 29 C. difficile strains from other hospitals to efrotomycin, ciprofloxacin, and six other antimicrobials was tested in vitro by agar dilution. Ciprofloxin (MIC 50 and M...

Full description

Saved in:
Bibliographic Details
Published inDiagnostic microbiology and infectious disease Vol. 6; no. 1; pp. 49 - 52
Main Authors Clabots, C.R., Shanholtzer, C.J., Peterson, L.R., Gerding, D.N.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 1987
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The susceptibility of 69 clinical isolates of Clostridium difficile from the Minneapolis Veterans Administration Medical Center and 29 C. difficile strains from other hospitals to efrotomycin, ciprofloxacin, and six other antimicrobials was tested in vitro by agar dilution. Ciprofloxin (MIC 50 and MIC 90 = 8 mcg/ml) was only moderately active whereas efrotomycin (MIC 50 = 0.125, MIC 90 = 0.25 mcg/ml) was highly active against C. difficile .
AbstractList The susceptibility of 69 clinical isolates of Clostridium difficile from the Minneapolis Veterans Administration Medical Center and 29 C. difficile strains from other hospitals to efrotomycin, ciprofloxacin, and six other antimicrobials was tested in vitro by agar dilution. Ciprofloxin (MIC50 and MIC90 = 8 mcg/ml) was only moderately active whereas efrotomycin (MIC50 = 0.125, MIC90 = 0.25 mcg/ml) was highly active against C. difficile.
The susceptibility of 69 clinical isolates of Clostridium difficile from the Minneapolis Veterans Administration Medical Center and 29 C. difficile strains from other hospitals to efrotomycin, ciprofloxacin, and six other antimicrobials was tested in vitro by agar dilution. Ciprofloxin (MIC 50 and MIC 90 = 8 mcg/ml) was only moderately active whereas efrotomycin (MIC 50 = 0.125, MIC 90 = 0.25 mcg/ml) was highly active against C. difficile .
Author Gerding, D.N.
Shanholtzer, C.J.
Clabots, C.R.
Peterson, L.R.
Author_xml – sequence: 1
  givenname: C.R.
  surname: Clabots
  fullname: Clabots, C.R.
– sequence: 2
  givenname: C.J.
  surname: Shanholtzer
  fullname: Shanholtzer, C.J.
– sequence: 3
  givenname: L.R.
  surname: Peterson
  fullname: Peterson, L.R.
– sequence: 4
  givenname: D.N.
  surname: Gerding
  fullname: Gerding, D.N.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7400391$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/3802745$$D View this record in MEDLINE/PubMed
BookMark eNp9kMGKFDEQhoOsrLOrb6CQg8gKtlY6PZ3kIsiw6sKCFz2HdLqipd3JmmSWnbe3Z2eYo6ekqK9-fr4LdhZTRMZeCngvQPQfQMm20drIK63eGhBCNuIJWwmtTAOg4IytTsgzdlHKbwDRmg7O2bnU0KpuvWJ_biK_p5oTd77S8tvxFDiGnGqad57iO-7pLqcwpQf3OLo48kIPPNVfmJep0kw-p4HcVLj76SiWyjdTKjXTSNuZjxQCeZrwOXsaFghfHN9L9uPz9ffN1-b225ebzafbxksQtemw7eWwVq1A08IoZDuooAbU4Ma-6xV0ej323guBzvcgOqcxGC2cdIBgjLxkbw65S--_WyzVzlQ8TpOLmLbFKiV7I1S_gN0BXPqXkjHYu0yzyzsrwO4d271AuxdotbKPjq1Yzl4d87fDjOPp6Ch12b8-7l3xbgrZRU_lhKkOQJp9zMcDhouLe8JsiyeMHkfK6KsdE_2_xz_LWZrK
CODEN DMIDDZ
CitedBy_id crossref_primary_10_1016_S0891_5520_20_30523_7
crossref_primary_10_1038_ja_2017_62
crossref_primary_10_1007_s10096_011_1231_0
crossref_primary_10_1128_CMR_16_2_175_188_2003
crossref_primary_10_1016_S0924_8579_09_70013_5
crossref_primary_10_1086_521859
crossref_primary_10_1016_0002_9343_89_90476_2
Cites_doi 10.1128/AAC.28.6.842
10.1128/JCM.19.3.321-325.1984
10.1128/AAC.17.4.695
10.1128/AAC.28.6.847
10.1128/AAC.25.3.319
10.3382/ps.0621612
10.1128/AAC.25.4.504
10.1093/jac/15.5.648-a
10.1128/AAC.24.4.568
10.1128/AAC.26.5.757
10.7164/antibiotics.29.1083
ContentType Journal Article
Copyright 1987
1988 INIST-CNRS
Copyright_xml – notice: 1987
– notice: 1988 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/0732-8893(87)90113-1
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1879-0070
EndPage 52
ExternalDocumentID 10_1016_0732_8893_87_90113_1
3802745
7400391
0732889387901131
Genre Research Support, U.S. Gov't, Non-P.H.S
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFFNX
AFKWA
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AI.
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CJTIS
CNWQP
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMG
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LUGTX
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OD-
OO.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SIN
SPCBC
SSH
SSI
SSZ
T5K
UNMZH
VH1
WUQ
XPP
Z5R
ZGI
ZXP
~G-
08R
AAPBV
ABPIF
ABPTK
IQODW
AAXKI
AFCTW
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c301t-4e263b5721e920d132b7f7be80ad64670485d6cc11eac6014a8ef981a3a0e0993
ISSN 0732-8893
IngestDate Fri Aug 16 04:10:04 EDT 2024
Thu Sep 26 18:39:30 EDT 2024
Sat Sep 28 08:39:37 EDT 2024
Sun Oct 29 17:10:27 EDT 2023
Fri Feb 23 02:33:15 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Antibiotic
Sensitivity resistance
Drug susceptibility test
Clostridiaceae
Clostridium difficile
Minimum inhibitory concentration
Clostridiales
Bacteria
Erythromycin
Antibacterial agent
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c301t-4e263b5721e920d132b7f7be80ad64670485d6cc11eac6014a8ef981a3a0e0993
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 3802745
PQID 77369176
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_77369176
crossref_primary_10_1016_0732_8893_87_90113_1
pubmed_primary_3802745
pascalfrancis_primary_7400391
elsevier_sciencedirect_doi_10_1016_0732_8893_87_90113_1
PublicationCentury 1900
PublicationDate 1987
1987-Jan
1987-1-00
19870101
PublicationDateYYYYMMDD 1987-01-01
PublicationDate_xml – year: 1987
  text: 1987
PublicationDecade 1980
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Diagnostic microbiology and infectious disease
PublicationTitleAlternate Diagn Microbiol Infect Dis
PublicationYear 1987
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Steers, Foltz, Graves (BIB15) 1959; 9
Goodman, Fliegelman, Trenholme, Kaplan (BIB12) 1984; 25
George, Kirby, Sutter, Finegold (BIB11) 1979
Feighner (BIB8) 1983
Barry (BIB2) 1978
Foster, Harris (BIB9) 1976; 43
Fass (BIB7) 1983; 24
Stutz, Johnson, Judith, Miller (BIB16) 1983; 62
Dzink, Bartlett (BIB6) 1980; 17
Ball (BIB1) 1986
Pantosti, Luzzi, Cardines, Gianfrilli (BIB14) 1985; 28
Chow, Cheng, Bartlett (BIB5) 1985; 28
Swenson, Thornsberry (BIB17) 1984; 19
Frost, Valiant, Weissberger, Dulaney (BIB10) 1976; 29
Brumfitt, Franklin, Grady, Hamilton-Miller, Iliffe (BIB3) 1984; 26
Newsome, Matthews, Rampling (BIB13) 1985; 15
Chin, Neu (BIB4) 1984; 25
Chin (10.1016/0732-8893(87)90113-1_BIB4) 1984; 25
Goodman (10.1016/0732-8893(87)90113-1_BIB12) 1984; 25
Dzink (10.1016/0732-8893(87)90113-1_BIB6) 1980; 17
Chow (10.1016/0732-8893(87)90113-1_BIB5) 1985; 28
Feighner (10.1016/0732-8893(87)90113-1_BIB8) 1983
George (10.1016/0732-8893(87)90113-1_BIB11) 1979
Swenson (10.1016/0732-8893(87)90113-1_BIB17) 1984; 19
Ball (10.1016/0732-8893(87)90113-1_BIB1) 1986
Foster (10.1016/0732-8893(87)90113-1_BIB9) 1976; 43
Stutz (10.1016/0732-8893(87)90113-1_BIB16) 1983; 62
Frost (10.1016/0732-8893(87)90113-1_BIB10) 1976; 29
Steers (10.1016/0732-8893(87)90113-1_BIB15) 1959; 9
Barry (10.1016/0732-8893(87)90113-1_BIB2) 1978
Brumfitt (10.1016/0732-8893(87)90113-1_BIB3) 1984; 26
Pantosti (10.1016/0732-8893(87)90113-1_BIB14) 1985; 28
Fass (10.1016/0732-8893(87)90113-1_BIB7) 1983; 24
Newsome (10.1016/0732-8893(87)90113-1_BIB13) 1985; 15
References_xml – volume: 43
  start-page: 252
  year: 1976
  ident: BIB9
  article-title: Efrotomycin, a drug for swine dysentery control
  publication-title: J Anim Sci
  contributor:
    fullname: Harris
– volume: 25
  start-page: 504
  year: 1984
  ident: BIB12
  article-title: Comparative in vitro activity of ciprofloxacin against
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Kaplan
– start-page: 214
  year: 1983
  ident: BIB8
  publication-title: Abstract of the 23rd ICAAC
  contributor:
    fullname: Feighner
– volume: 9
  start-page: 307
  year: 1959
  ident: BIB15
  article-title: An inocula replicating apparatus for routine testing of anaerobic bacteria susceptibility to antibiotics
  publication-title: Antibiot Agents Chemother
  contributor:
    fullname: Graves
– volume: 29
  start-page: 1083
  year: 1976
  ident: BIB10
  article-title: Antibacterial activity of efrotomycin
  publication-title: J Antibiotic
  contributor:
    fullname: Dulaney
– volume: 17
  start-page: 695
  year: 1980
  ident: BIB6
  article-title: In vitro susceptibility of
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Bartlett
– start-page: 267
  year: 1979
  ident: BIB11
  article-title: Antimicrobial susceptibility of
  publication-title: Microbiology—1979
  contributor:
    fullname: Finegold
– volume: 25
  start-page: 319
  year: 1984
  ident: BIB4
  article-title: Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Neu
– year: 1986
  ident: BIB1
  article-title: The safety and tolerance of ciprofloxacin
  publication-title: J Antimicrob Chemother
  contributor:
    fullname: Ball
– start-page: 76
  year: 1978
  end-page: 91
  ident: BIB2
  article-title: Agar dilution techniques
  publication-title: The Antimicrobic Susceptibility Test: Principles and Practices
  contributor:
    fullname: Barry
– volume: 26
  start-page: 757
  year: 1984
  ident: BIB3
  article-title: Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Iliffe
– volume: 19
  start-page: 321
  year: 1984
  ident: BIB17
  article-title: Preparing inoculum for susceptibility testing of anaerobes
  publication-title: J Clin Microbiol
  contributor:
    fullname: Thornsberry
– volume: 28
  start-page: 842
  year: 1985
  ident: BIB5
  article-title: In vitro susceptibility of
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Bartlett
– volume: 24
  start-page: 568
  year: 1983
  ident: BIB7
  article-title: In vitro activity of ciprofloxacin (Bay 0 9867)
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Fass
– volume: 62
  start-page: 1612
  year: 1983
  ident: BIB16
  article-title: In vitro and in vivo evaluations of the antibiotic efrotomycin
  publication-title: Poult Sci
  contributor:
    fullname: Miller
– volume: 15
  start-page: 648
  year: 1985
  ident: BIB13
  article-title: Susceptibility of
  publication-title: J Antimicrob Chemother
  contributor:
    fullname: Rampling
– volume: 28
  start-page: 847
  year: 1985
  ident: BIB14
  article-title: Comparison of the in vitro activities of teicoplanin and vancomycin against
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Gianfrilli
– volume: 43
  start-page: 252
  year: 1976
  ident: 10.1016/0732-8893(87)90113-1_BIB9
  article-title: Efrotomycin, a drug for swine dysentery control
  publication-title: J Anim Sci
  contributor:
    fullname: Foster
– volume: 9
  start-page: 307
  year: 1959
  ident: 10.1016/0732-8893(87)90113-1_BIB15
  article-title: An inocula replicating apparatus for routine testing of anaerobic bacteria susceptibility to antibiotics
  publication-title: Antibiot Agents Chemother
  contributor:
    fullname: Steers
– start-page: 267
  year: 1979
  ident: 10.1016/0732-8893(87)90113-1_BIB11
  article-title: Antimicrobial susceptibility of Clostridium difficile
  contributor:
    fullname: George
– year: 1986
  ident: 10.1016/0732-8893(87)90113-1_BIB1
  article-title: The safety and tolerance of ciprofloxacin
  publication-title: J Antimicrob Chemother
  contributor:
    fullname: Ball
– volume: 28
  start-page: 842
  year: 1985
  ident: 10.1016/0732-8893(87)90113-1_BIB5
  article-title: In vitro susceptibility of Clostridium difficile to new betalactam and quinolone antibiotics
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.28.6.842
  contributor:
    fullname: Chow
– start-page: 214
  year: 1983
  ident: 10.1016/0732-8893(87)90113-1_BIB8
  contributor:
    fullname: Feighner
– volume: 19
  start-page: 321
  year: 1984
  ident: 10.1016/0732-8893(87)90113-1_BIB17
  article-title: Preparing inoculum for susceptibility testing of anaerobes
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.19.3.321-325.1984
  contributor:
    fullname: Swenson
– volume: 17
  start-page: 695
  year: 1980
  ident: 10.1016/0732-8893(87)90113-1_BIB6
  article-title: In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.17.4.695
  contributor:
    fullname: Dzink
– volume: 28
  start-page: 847
  year: 1985
  ident: 10.1016/0732-8893(87)90113-1_BIB14
  article-title: Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.28.6.847
  contributor:
    fullname: Pantosti
– volume: 25
  start-page: 319
  year: 1984
  ident: 10.1016/0732-8893(87)90113-1_BIB4
  article-title: Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.25.3.319
  contributor:
    fullname: Chin
– volume: 62
  start-page: 1612
  year: 1983
  ident: 10.1016/0732-8893(87)90113-1_BIB16
  article-title: In vitro and in vivo evaluations of the antibiotic efrotomycin
  publication-title: Poult Sci
  doi: 10.3382/ps.0621612
  contributor:
    fullname: Stutz
– volume: 25
  start-page: 504
  year: 1984
  ident: 10.1016/0732-8893(87)90113-1_BIB12
  article-title: Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.25.4.504
  contributor:
    fullname: Goodman
– volume: 15
  start-page: 648
  year: 1985
  ident: 10.1016/0732-8893(87)90113-1_BIB13
  article-title: Susceptibility of Clostridium difficile strains to new antibiotics: quinolones, efrotomycin, teicoplanin and imipenem
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/15.5.648-a
  contributor:
    fullname: Newsome
– start-page: 76
  year: 1978
  ident: 10.1016/0732-8893(87)90113-1_BIB2
  article-title: Agar dilution techniques
  contributor:
    fullname: Barry
– volume: 24
  start-page: 568
  year: 1983
  ident: 10.1016/0732-8893(87)90113-1_BIB7
  article-title: In vitro activity of ciprofloxacin (Bay 0 9867)
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.24.4.568
  contributor:
    fullname: Fass
– volume: 26
  start-page: 757
  year: 1984
  ident: 10.1016/0732-8893(87)90113-1_BIB3
  article-title: Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.26.5.757
  contributor:
    fullname: Brumfitt
– volume: 29
  start-page: 1083
  year: 1976
  ident: 10.1016/0732-8893(87)90113-1_BIB10
  article-title: Antibacterial activity of efrotomycin
  publication-title: J Antibiotic
  doi: 10.7164/antibiotics.29.1083
  contributor:
    fullname: Frost
SSID ssj0012940
Score 1.3641418
Snippet The susceptibility of 69 clinical isolates of Clostridium difficile from the Minneapolis Veterans Administration Medical Center and 29 C. difficile strains...
The susceptibility of 69 clinical isolates of Clostridium difficile from the Minneapolis Veterans Administration Medical Center and 29 C. difficile strains...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 49
SubjectTerms Anti-Bacterial Agents - pharmacology
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Ciprofloxacin - pharmacology
Clostridium - drug effects
Humans
Medical sciences
Microbial Sensitivity Tests
Pharmacology. Drug treatments
Pyridones - pharmacology
Title In vitro activity of efrotomycin, ciprofloxacin, and six other antimicrobials against Clostridium difficile
URI https://dx.doi.org/10.1016/0732-8893(87)90113-1
https://www.ncbi.nlm.nih.gov/pubmed/3802745
https://search.proquest.com/docview/77369176
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqTiAkhGAwUWDgBx5AXUKutvM4dcAuYg_TJvYWOY4DEW0ydem07TfxIzm-JE0ZE7CXqLXiJMr3-Zzjk3NB6K30uWQyZo6XxdIBDcUdRrzIEVkMiykqkkDqKN9DsnsS7Z_Gp4PBz17U0qLJXHH9x7ySu6AKY4CrypL9D2S7i8IA_AZ84QgIw_GfMN6rxhdlM691RYwLG1whi3nd1LMrYaoDiFK15Z7Wl9wOaE95eTnWqVfwrylnpa7GpAop82-8BINxPJnWqqFHXi5muodKKcrpStDQjgnRU-Ve7fR-MScT4LU4__37z0RxrjFVDdwjt3PvfOcVSOHm2mYluvvuUmQ3ek-g_Qe9KZ_lPLftWHbcQ3fpvFDujaUvrc2nWQn3BHkD8pmZnomuNCKZ0cRRVYn6MpvcoKaRv6b8qdXkpjTuDR1h3BXdrcCQ124XlYMbOv5SL3bRiupUdSY8iDoH9tprgSorOERr2wdHXw-6r1ZBohNwu0u3qZo--dCNvWP0vb3VbabQwzN-Dgu0MJ1Vbt_6aBPo-DF6ZPcueNsQ8QkayGod3TPdTK_W0f0vNk7jKfqxV2HNTNwyE9cF7jFzC6_wcgsDbzCwEmtW4lVWYstK3GMl7lj5DJ18-ng82XVsWw9HgDZpnEgGJMxiGvgyCbzcD4OMFjSTzOM5Ab0NOiXOiRC-D0YBgS08Z7JImM9D7knY0IQbaFjVlXyOcAH6ShAZCpl7USgJ90SeB0kW6aJLUo6Q077h9MxUb0nbsEaFSKoQSRlNNSKpP0K0hSG1FqixLFMgz19mbq6g1t2ORroJwwi9aVFMQYCrr3K8krAQU0pDkviUjNCGAbebGjLlM4pf3PmhXqIHatEZj-ErNGzmC7kJNnSTvbbU_QVRoMVZ
link.rule.ids 315,783,787,4033,27937,27938,27939
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+activity+of+efrotomycin%2C+ciprofloxacin%2C+and+six+other+antimicrobials+against+Clostridium+difficile&rft.jtitle=Diagnostic+microbiology+and+infectious+disease&rft.au=Clabots%2C+C.R.&rft.au=Shanholtzer%2C+C.J.&rft.au=Peterson%2C+L.R.&rft.au=Gerding%2C+D.N.&rft.date=1987&rft.pub=Elsevier+Inc&rft.issn=0732-8893&rft.eissn=1879-0070&rft.volume=6&rft.issue=1&rft.spage=49&rft.epage=52&rft_id=info:doi/10.1016%2F0732-8893%2887%2990113-1&rft.externalDocID=0732889387901131
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-8893&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-8893&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-8893&client=summon